However, further research is warranted to fully understand the contribution of SRG3 overexpression to balancing between immune and metabolic homeostasis in adipose tissues and its potential relevance to metabolic diseases such as obesity and type 2 diabetes. The gene discussed is SMARCC1; the disease is metabolic disease.